161 results
Page 4 of 9
8-K
EX-99.1
h0e no22inalu8ri
1 Dec 20
Other Events
7:46am
8-K
EX-99.1
cqa2syg f133
5 Nov 20
Agios Reports Business Highlights and Third Quarter 2020 Financial Results
7:32am
8-K
EX-99.1
nd09f vzq6o
21 Sep 20
Other Events
7:14am
8-K
EX-99.1
oua1leq3r9no3 6klz6o
8 Sep 20
Agios Appoints Jonathan Biller as Chief Financial Officer, Head of Legal and Corporate Affairs
4:09pm
8-K
EX-99.1
d5qo9
30 Jul 20
Agios Reports Business Highlights and Second Quarter 2020 Financial Results
7:17am
8-K
cftf jebq
12 Jun 20
Entry into a Material Definitive Agreement
7:04am
8-K
EX-99.3
xay8h
12 Jun 20
Entry into a Material Definitive Agreement
7:04am
8-K
EX-99.2
4y8f71htd 5f
12 Jun 20
Entry into a Material Definitive Agreement
7:04am
8-K
EX-99.1
tkk8uz64x3
12 Jun 20
Entry into a Material Definitive Agreement
7:04am
8-K
EX-99.1
0je9miz5uu o222
30 Apr 20
Agios Reports First Quarter 2020 Financial Results and Provides Update on Business Operations andCOVID-19 Response
7:19am
8-K
EX-99.1
6a0e y04w
13 Feb 20
Agios Reports Fourth Quarter and Full Year 2019 Financial Results
7:40am
8-K
EX-99.1
jdlqeyd jt6t8tw
13 Jan 20
Regulation FD Disclosure
4:32pm
8-K
EX-99.1
hxc3s
13 Jan 20
Agios Announces “Agios 2025” Strategic Vision and Highlights 2020 Milestones
6:43am
8-K
EX-99.2
zve5j1pk
9 Dec 19
Agios EstablishesProof-of-Concept for Mitapivat inNon-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results
4:02pm
8-K
EX-99.1
fly9hm6acm8175kgh
9 Dec 19
Agios EstablishesProof-of-Concept for Mitapivat inNon-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results
4:02pm